Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.4 USD | -2.56% | -0.09% | -19.29% |
05-10 | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
05-09 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -1.12% | -0.09% | -19.29% | -34.38% | +26.85% | 3.11B |
Technical Rankings Surperformance
- Stock Market
- Equities
- ARWR Stock
- Charts Arrowhead Pharmaceuticals, Inc.
- Comparison Chart